Guided Meditation During Radiation Therapy for Breast and Gynecological Malignancies

NCT ID: NCT07166042

Last Updated: 2025-10-03

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

PHASE3

Total Enrollment

34 participants

Study Classification

INTERVENTIONAL

Study Start Date

2025-09-25

Study Completion Date

2028-09-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The goal of this study is to assess the effect of brief mindfulness-guided meditations during radiation therapy (RT) for patients with anxiety related to RT for breast and gynecological cancers.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Breast Cancer Gynecologic Cancer

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Guided Meditation Intervention

Group Type EXPERIMENTAL

10-15 minute, Audio-Recorded Guided Mediation Practices

Intervention Type BEHAVIORAL

The 5 mindfulness practices, all of which have been validated in prior research.

Body Scan practice will consist of how to direct non-judgmental attention to different regions of the body

The Mindful Breathing practice will consist of focused attention on the breath and metacognitive monitoring and acceptance of discursive thoughts, negative emotions, and body sensations.

The Mindfulness of Discomfort practice will consist of instruction in how to "zoom in" to deconstruct discomfort and precisely map each feelings' spatial location, use mindful breathing to "zoom out" and broaden the field of awareness to include neglected sensory elements, and shift attention from unpleasant feelings to neutral/pleasant sensations or experiences.

The Savoring practice will consist of instruction in identifying and amplifying pleasant memories.

The Loving-Kindness practice will consist of instruction in cultivating feeling of warmth and compassion toward the self and others.

Standard of Care

Group Type NO_INTERVENTION

No interventions assigned to this group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

10-15 minute, Audio-Recorded Guided Mediation Practices

The 5 mindfulness practices, all of which have been validated in prior research.

Body Scan practice will consist of how to direct non-judgmental attention to different regions of the body

The Mindful Breathing practice will consist of focused attention on the breath and metacognitive monitoring and acceptance of discursive thoughts, negative emotions, and body sensations.

The Mindfulness of Discomfort practice will consist of instruction in how to "zoom in" to deconstruct discomfort and precisely map each feelings' spatial location, use mindful breathing to "zoom out" and broaden the field of awareness to include neglected sensory elements, and shift attention from unpleasant feelings to neutral/pleasant sensations or experiences.

The Savoring practice will consist of instruction in identifying and amplifying pleasant memories.

The Loving-Kindness practice will consist of instruction in cultivating feeling of warmth and compassion toward the self and others.

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Participant aged ≥ 18 years.
* Diagnosis of breast or gynelogical cancer.
* Eligible to receive 15-25 daily radiation therapy treatments for breast or gynelogical cancer.
* Willing to participate in either the guided meditation or standard of care control arm, regardless of treatment assignment.
* Karnofsky performance score ≥ 60 or ECOG performance score ≤ 2.
* Able to provide informed consent and willing to sign an approved consent form that conforms to federal and institutional guidelines.

Exclusion Criteria

* Active suicidal ideation or active psychotic state in the opinion of the investigator.
* Patient is receiving deep inspiration breath hold treatment.
* An unstable illness that, in the opinion of the investigator, would interfere with study treatment.
* Prior radiation therapy.
* Inability to understand and/or speak the English language.
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University of Utah

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Lindsay Burt, MD

Role: PRINCIPAL_INVESTIGATOR

Huntsman Cancer Institute/ University of Utah

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Huntsman Cancer Institute at University of Utah

Salt Lake City, Utah, United States

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

United States

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Rachel R. Kingford

Role: CONTACT

801-585-0115

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Rachel Kingsford

Role: primary

801-585-0115

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

HCI192768

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Menopause and Meditation for Breast Cancer Survivors
NCT00156416 COMPLETED PHASE1/PHASE2
Perioperative Mindfulness Proposal
NCT04049214 RECRUITING NA